文献速递腹部MR

基于磁敏感加权成像与T2加权成像的MRI影像组学预测肝细胞癌患者微血管侵犯

Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging.
PubMed 文献 · Radiol Med · 2024-07-13

前瞻性纳入189例早期肝细胞癌患者训练和测试模型,另34例外部验证,从SWI和T2WI提取影像组学特征构建模型。甲胎蛋白>400 ng/mL、肿瘤直径>5 cm、无假包膜为MVI独立危险因素。验证集影像组学模型AUC为0.888,优于临床模型0.602,联合列线图AUC达0.948。

要点

  • 甲胎蛋白>400 ng/mL、肿瘤直径>5 cm、无假包膜是MVI独立危险因素。
  • 外部验证集影像组学模型AUC为0.888,临床模型为0.602。
  • 影像组学联合临床因素列线图AUC达0.948,诊断效能最佳。

核心结论

  • SWI和T2WI衍生的影像组学特征有助于无创、准确地识别早期肝细胞癌的微血管侵犯,影像组学与临床因素整合的列线图诊断效能满意并具有潜在临床获益。

研究设计与样本

  • 前瞻性队列,189例肝细胞癌患者用于模型训练和测试,另34例用于外部验证;手动分割肿瘤后从SWI和T2WI提取影像组学特征,采用方差过滤、t检验、LASSO回归和随机森林筛选特征,建立四种机器学习分类器模型及临床模型,并以五折交叉验证的ROC曲线分析评估诊断效能。

诊断标准与关键数值

  • 甲胎蛋白>400 ng/mL(OR 2.50;95%CI 1.239-5.047)、肿瘤直径>5 cm(OR 2.39;95%CI 1.178-4.839)、无假包膜(OR 2.053;95%CI 1.007-4.202)为MVI独立危险因素;最佳影像组学模型训练集和测试集AUC分别为1.000和0.882,临床模型分别为0.688和0.6691;验证集影像组学模型AUC为0.888、临床模型AUC为0.602;影像组学联合临床因素列线图AUC为0.948。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The accurate identification of microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) is of great clinical importance.

PURPOSE: To develop a radiomics nomogram based on susceptibility-weighted imaging (SWI) and T2-weighted imaging (T2WI) for predicting MVI in early-stage (Barcelona Clinic Liver Cancer stages 0 and A) HCC patients.

MATERIALS AND METHODS: A prospective cohort of 189 participants with HCC was included for model training and testing, and an additional 34 participants were enrolled for external validation. ITK-SNAP was used to manually segment the tumour, and PyRadiomics was used to extract radiomic features from the SWI and T2W images. Variance filtering, student's t test, least absolute shrinkage and selection operator regression and random forest (RF) were applied to select meaningful features. Four machine learning classifiers, including K-nearest neighbour, RF, logistic regression and support vector machine-based models, were established. Independent clinical and radiological risk factors were also determined to establish a clinical model. The best radiomics and clinical models were further evaluated in the validation set. In addition, a nomogram was constructed from the radiomic model and independent clinical factors. Diagnostic efficacy was evaluated by receiver operating characteristic curve analysis with fivefold cross-validation.

RESULTS: AFP levels greater than 400 ng/mL [odds ratio (OR) 2.50; 95% confidence interval (CI) 1.239-5.047], tumour diameter greater than 5 cm (OR 2.39; 95% CI 1.178-4.839), and absence of pseudocapsule (OR 2.053; 95% CI 1.007-4.202) were found to be independent risk factors for MVI. The areas under the curve (AUCs) of the best radiomic model were 1.000 and 0.882 in the training and testing cohorts, respectively, while those of the clinical model were 0.688 and 0.6691. In the validation set, the radiomic model achieved better diagnostic performance (AUC = 0.888) than the clinical model (AUC = 0.602). The combination of clinical factors and the radiomic model yielded a nomogram with the best diagnostic performance (AUC = 0.948).

CONCLUSION: SWI and T2WI-derived radiomic features are valuable for noninvasively and accurately identifying MVI in early-stage HCC. Furthermore, the integration of radiomics and clinical factors yielded a predictive nomogram with satisfactory diagnostic performance and potential clinical benefits.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Geng Z, Wang S, Ma L, et al. Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging. Radiol Med. 2024. PMID: 38997568. doi:10.1007/s11547-024-01845-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。